Regeneron Pharmaceuticals (NASDAQ: REGN) Faces Investor Lawsuit Following Clinical Trial Setback
| Show full article |
|
This functionality is available for registred users only
|
-
Full nameRegeneron Pharmaceuticals Inc
-
Registration countryUSA
-
IndustryPharmaceutical Preparation and Biotechnology
-
М/S&P/F
*** /*** /***









